Page 27 - Read Online
P. 27

Frame et al.                                                                                                                                                     Investigating models for prostate cancer research

           as being more radiation-resistant . One report     the colony forming ability of selected subpopulations
                                            [15]
           showed that  stem-like cells from  the  Du145 cell line   of primary prostate epithelial cells, including stem-like
           were more resistant to  etoposide .  However,  there   cells and TA cells, were analyzed following treatment
                                          [21]
           is currently  no experimental evidence  determining   with etoposide  [Figure 3A].  Cancer stem-like cells
           the effect of chemotherapeutic agents specifically on   showed  increased ability  to form colonies  compared
           primary  prostate cancer stem-like  cells.  Therefore,   to TA cells post-treatment. Since etoposide is known to
































































           Figure 2: A combination of radiation treatment and Vorinostat has varied effects on viability and colony forming ability in a panel of cell
           lines and primary prostate epithelial cells. PNT1a, BPH-1, P4E6 and PC3 cells were treated with Vorinostat (10 µmol/L) or radiation (75
           Gy) or both and measured using alamar blue assay at 24 h (A), 48 h (B) and 72 h (C) post-treatment. Primary epithelial cultures from six
           patients, normal (2 samples) (D) and prostate cancer (4 samples) (E) were treated with Vorinostat (10 µmol/L) or radiation (75 Gy) or both
           and measured using alamar blue assay at 24 h post-treatment. Each symbol represents a different patient sample; (F) primary epithelial
           cultures from four patients were treated with 2 Gy radiation or three concentrations of Vorinostat (low: 0.625 µmol/L, medium: 2.5 µmol/L,
           high: 10 µmol/L) or both and assessed for colony forming ability 10-14 days after growth. Colony forming ability is presented as % surviving
           fraction
            306                                                                Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ December 6, 2017
   22   23   24   25   26   27   28   29   30   31   32